The immunosuppressive drug LF15-0195 acts also on glomerular lesions, by a change in cytoskeleton distribution in podocyte.
免疫抑制藥物 LF15-0195 也對腎小球病變產生作用,通過改變足細胞中的細胞骨架分佈。
Am J Nephrol 2024-07-29
Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy.
Canagliflozin 在具有膜性腎病的大鼠中逆轉 Th1/Th2 不平衡並促進足細胞自噬。
Front Immunol 2023-01-17
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
SGLT2 抑制劑透過減少發炎並增強自噬,緩解狼瘡性腎炎中的足細胞損傷。
Ann Rheum Dis 2023-10-12
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.
成人患者腎小球細胞病變的管理:來自ERA免疫腎病學工作小組的最新資訊。
Nephrol Dial Transplant 2024-03-28
Protective Role of the Podocyte IL-15 / STAT5 Pathway in Focal Segmental Glomerulosclerosis.
腎小球節段性硬化症中足細胞 IL-15 / STAT5 途徑的保護作用。
Kidney Int Rep 2024-05-20
Cyclosporine A protects podocytes by regulating transgelin in adriamycin-induced podocyte injury.
Cyclosporine A透過調節adriamycin誘導的腎小球細胞損傷中的transgelin來保護腎小球細胞。
Kidney Blood Press Res 2024-07-02
Cyclosporine A (CsA)穩定足細胞內的足突細胞骨架,降低蛋白尿。研究指出,CsA影響蛋白尿的機制涉及到cofilin-1、transgelin、nephrin和synaptopodin等蛋白質。在大鼠腎病和足細胞培養實驗中,CsA治療降低蛋白尿,修復足突結構,並使transgelin、nephrin和synaptopodin表達正常化。此外,CsA也提升KLF-4表達,與transgelin水平下降有關。CsA透過上調KLF-4調節transgelin水平,保護足細胞。
PubMedDOI
Investigating FSGS-like Injury in Zebrafish Larvae by Nifurpirinol: Efficacy and Molecular Insight.
利用Nifurpirinol 探討斑馬魚幼體中 FSGS-like 損傷:功效和分子洞察。
Am J Physiol Renal Physiol 2024-07-11
Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis.
Astragaloside IV 透過抑制 TRAF6/NF-κb 軸來緩解被動 Heymann 腎炎和足細胞損傷。
Ren Fail 2024-07-31